Viewpoints

Teledermatology in the COVID Era: No Turning Back Like it or not, teledermatology is here to stay. Here is what we've learned so far about where it works best.
Experts And Viewpoints, December 14, 2020
The Systemic Flaw in Clinical Trials Clinical trials not reporting -- or even determining -- the racial and ethnic composition of participants are a disservice to both clinicians and patients.
Experts And Viewpoints, October 09, 2020
COVID Skin Changes: The Hidden Racism in Documentation COVID-19 disproportionately affects persons of color. But you wouldn't know it from the images found in articles discussing skin changes associated with the infection.
Experts And Viewpoints, July 27, 2020
'COVID Toes', 'Kawasaki' Rash: 5 Cutaneous Signs in COVID-19 The number of skin changes suspected to be associated with COVID-19 keeps growing.
Experts And Viewpoints, May 08, 2020
The Nine-Headed Monster: Recalcitrant Warts Could checkpoint inhibitors provide a new treatment option for warts that just won't go away?
Experts And Viewpoints, February 12, 2020
Dupilumab in the Real World: Beware Adverse Effects The experience with dupilumab, the first biologic for the treatment of atopic dermatitis, has demonstrated some marked contrasts to that seen in clinical trials.
Experts And Viewpoints, January 15, 2020
Palmoplantar Psoriasis: Does a New Drug Offer Some Relief? Palmoplantar psoriasis is miserable to live with and equally miserable to treat. Will guselkumab prove to be a better option?
Experts And Viewpoints, November 20, 2019
Checkpoint Inhibitors: Powerful Drugs With Severe Side Effects Would you recognize a cutaneous adverse effect of these powerful agents? A new study can help -- and provides key information about management.
Experts And Viewpoints, June 12, 2019
DPP4-Inhibitors and Onset of Bullous Pemphigoid Which patients are at risk of developing this skin condition?
Experts And Viewpoints, March 27, 2019
The Triggers of Systemic Contact Dermatitis Which patients with atopic dermatitis are at risk of developing systemic contact dermatitis?
Experts And Viewpoints, February 07, 2019
Psoriasis and IBD: Is This Comorbidity for Real? Psoriasis vulgaris seems to be linked not only with RA and CVD but also with IBD.
Experts And Viewpoints, January 11, 2019
Dysplastic Nevi: Monitoring and Management Is it safe to observe moderately dysplastic nevi with positive histologic margins, or is the risk for cutaneous melanoma too high?
Experts And Viewpoints, October 25, 2018
Atopic Dermatitis: Five Promising Targeted Therapies Finally, patients with atopic dermatitis will have a range of treatment options.
Experts And Viewpoints, September 24, 2018
Rosacea: 5 Things to Know These five things include some lesser known, but critically important, facts about rosacea and its management.
Experts And Viewpoints, September 19, 2018
Hyperhidrosis: Five Things to Know Public awareness of this medical condition is driving many patients out of the woodwork and into their provider's offices. Be ready to discuss the treatment options.
Experts And Viewpoints, July 27, 2018
Hydrochlorothiazide and Skin Cancer: Raise the Red Flag A dramatic association has been found between this common diuretic and nonmelanoma skin cancer.
Experts And Viewpoints, May 04, 2018
Can This Topical Cream Prevent Nonmelanoma Skin Cancer? A study tested whether prophylactic application of topical fluorouracil can prevent nonmelanoma skin cancer.
Experts And Viewpoints, March 08, 2018
The 'Ugly Duckling' Rule in Melanoma Self-exam Compared with the more traditional ABCD rule, does the 'ugly duckling' sign improve melanoma detection?
Experts And Viewpoints, February 08, 2018
Transplantation and Risk for Malignant Melanoma A study of renal transplant patients shows a 5x increased risk for malignant melanoma.
Experts And Viewpoints, January 05, 2018
Psoriasis: Disease Duration and CV Risk Disease duration joins severity as a factor driving CV risk in patients with psoriasis, but the right therapy can lower this risk.
Experts And Viewpoints, November 21, 2017

No Results